Information Provided By:
Fly News Breaks for August 3, 2018
CLX
Aug 3, 2018 | 09:15 EDT
BMO Capital analyst Shannon Coyne raised her price target on Clorox to $153 and kept her Outperform rating after its Q4 earnings beat driven by better than expected gross margins and expense controls. The analyst notes that the company's pricing power is "higher than most believe", and expects its "strong innovation track record and lead in digital transformation" to produce a relative outperformance in sales and earnings.